Literature DB >> 1377002

TP53 tumor suppressor gene: a model for investigating human mutagenesis.

C Caron de Fromentel1, T Soussi.   

Abstract

More than 350 independent point mutations of the TP53 gene, found in a wide variety of human cancers, were compiled and analysed. From this study, we confirm the presence of four hot-spot regions which colocalize with some highly conserved domains of the protein. We also define a new hot-spot region which is observed predominantly in lung tumors. Analysis of the mutational events suggests the direct involvement of environmental carcinogens in lung tumors and hepatocarcinomas, and spontaneous mutagenesis generating essentially CpG transitions in most of the remaining ones. Furthermore, we demonstrate in this work that the TP53 gene is an informative model with which to study the molecular mechanisms of mutagenesis in the human genome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377002     DOI: 10.1002/gcc.2870040102

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  122 in total

Review 1.  Cancer risks from germline p53 mutations.

Authors:  T Frebourg; S H Friend
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

3.  p53 gene alterations and protein accumulation in colorectal cancer.

Authors:  R Bertorelle; G Esposito; C Belluco; L Bonaldi; A Del Mistro; D Nitti; M Lise; L Chieco-Bianchi
Journal:  Clin Mol Pathol       Date:  1996-04

4.  The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.

Authors:  Siddharth Singh; Manoj Kumar; Sanjeev Kumar; Shrinka Sen; Pawan Upadhyay; Sayan Bhattacharjee; Naveen M; Vivek Singh Tomar; Siddhartha Roy; Amit Dutt; Tapas K Kundu
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

5.  Ultraviolet-induced p53 mutations in atypical fibroxanthoma.

Authors:  A P Dei Tos; R Maestro; C Doglioni; D Gasparotto; M Boiocchi; L Laurino; C D Fletcher
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 6.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

7.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

9.  Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.

Authors:  R Shipman; P Schraml; M Colombi; G Raefle; C U Ludwig
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

10.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.